HCID 118061136, compound → HCID 118060876, compound
Reaction equation
[CH3:1][N:2]1[CH:6]=[C:5]([NH:7][C:8]([C:10]2[N:11]=[C:12]([C:15]3[CH:20]=[CH:19][N:18]=[C:17]([NH:21][CH2:22][C:23]([F:26])([F:25])[F:24])[CH:16]=3)[O:13][CH:14]=2)=[O:9])[C:4]([N:27]2[CH2:31][CH2:30][CH:29]([CH3:32])[C:28]2=[O:33])=[N:3]1>CCCCCC.C(O)C>[CH3:1][N:2]1[CH:6]=[C:5]([NH:7][C:8]([C:10]2[N:11]=[C:12]([C:15]3[CH:20]=[CH:19][N:18]=[C:17]([NH:21][CH2:22][C:23]([F:25])([F:26])[F:24])[CH:16]=3)[O:13][CH:14]=2)=[O:9])[C:4]([N:27]2[CH2:31][CH2:30][C@H:29]([CH3:32])[C:28]2=[O:33])=[N:3]1Participants
3
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Procedure
Racemic N-(1-methyl-3-(3-methyl-2-oxopyrrolidin-1-yl)-1H-pyrazol-4-yl)-2-(2-((2,2,2-trifluoroethyl)amino)pyridin-4-yl)-1,3-oxazole-4-carboxamide (399 mg) was resolved by HPLC (column: CHIRALPAK IA (trade name), 50 mmID×500 mL, manufactured by Daicel Chemical Industries, mobile phase: hexane/ethanol=500/500), and the compound (186.7 mg) having a shorter retention time was recrystallized from THF/diisopropyl ether to give the title compound (183.7 mg).
Workup
- customwas recrystallized from THF/diisopropyl ether
Sources & evidence
- ORD record
- ord-edcf0c7bdc484436a58cf9ba3c69aa7b
- Source dataset
- uspto-grants-2016_04
- Patent number
- US09321757B2
Reaction notes
Loading…